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The purpose of this study was to determine the changes in prescribing habits of 
active members of American Association of Endodontics (AAE) with regards to antibiotics 
in comparison to the findings reported by Yingling et al. in 1999. 
 The invitations to take the online survey were sent via email to 2593 active 
members. A response rate of 37.75% was obtained. It was determined to be adequate for 
analysis and for comparison to the results obtained by Yingling et al. Comparisons 
between the percentages shown in this survey and the previous survey were tested using a 
z-test. An ANOVA model was used to determine the relationships between predictive 
factors and the number of prescriptions written. 
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The change in distribution of respondents was notable with an increase in younger 
clinicians (25% in 1999 to 36% at present). They were more likely to be in private practice 
and much less in part-time academic and private practice setting. The number of patients 
being seen per week and the number of prescriptions written per week also decreased in 
comparison (p<0.001). For all the considered factors, it was also noted that board certified 
endodontists were prescribing less antibiotics per week. A positive correlation was noted 
for number of years in practice (p=0.0006), type of practice (p<0.001) and number of 
prescriptions written per week. 
Changes in choice of antibiotics were also noted. There was a decrease in use of 
Penicillin (61.48% to 43%), an increase in the use of Amoxicillin (27.5% to 37.6%), and 
an increase in use clindamycin (45.3% to 64%) for patients with no medical allergies. As 
for patients with medical allergies, there was a steep incline in the use of clindamycin 
(56.03% to 90.3%) as first choice to an increase in azithromycin (7.4% to 38%) as a 
second choice. 
 An improved trend was noted with a significant decrease in use of antibiotics in 
managing most of the endodontic scenarios given. Antibiotic use in cases of irreversible 
pulpitis significantly dropped from 16.76% to 12% (p<0.05); in necrotic pulps with acute 
apical periodontitis with no swelling, a significant decline from 53.9% to 28.3% (p<0.001); 
significant decreases were also noted for necrotic pulp with chronic apical periodontitis 
with no/mild symptoms, 18.8% to 16.1% (p=0.029), and necrotic pulp with acute apical 
periodontitis with swelling and mod/severe symptoms, 99.2% to 92.4% (p<0.001). An 
exception was noted for necrotic pulp with chronic apical periodontitis with a sinus tract 
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where there was a significant increase in antibiotic use from 11.9% to 29.1% (p<0.001).   
Many clinicians (19%) were still giving antibiotics due to soliciting of patients and 
referring general dentists in fear of losing referrals. A disturbing find is that 50% of the 
respondents were using antibiotics to manage post treatment flare-ups and pain, while 13% 
were using antibiotics for inter-appointment pain.  
          As for prophylactic antibiotics, most clinicians were aware of the new AHA/ADA 
guidelines and were abiding by them. Most of the clinicians responding to survey were 
choosing the appropriate antibiotics and regimen (i.e. dosage, loading dose, and duration). 
Although there is an improvement in trends, it has to be noted that there is still an 
indiscriminate and overuse of antibiotics at large. There needs to be greater improvement 
in the use of antibiotics in endodontics, and a group effort as a specialty is needed in 
halting this alarming problem of antibiotic resistance globally.   
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INTRODUCTION 
 
Antibiotics are the second most commonly prescribed drug. The indiscriminate use 
of antibiotics by healthcare practitioners and general public at large is a major contributing 
factor to the rise in antibiotic resistance bacterial strains. Increase in incidence of 
methicillin-resistant Staphylococcus aureus (MRSA) has become a major concern. The 
systemic review of 76 studies by Tacconelli et al. reported a significant increase in risk of 
acquiring MRSA with previous exposure to antibiotics (9). According to the report in 2003 
by National Nosocomial Infections Surveillance system, 57.1% of S. aureus clinical 
isolates were methicillin-resistant (10). The Agency for Healthcare Research and Quality 
reported in a statistical brief significant growth of MRSA infections from 2,000 cases in 
1993 to 368,000 cases in 2005 (11,12). This is an alarming trend and a restraint in the 
indiscriminate use of antibiotics in all aspects of health care is needed (13). 
Dentists prescribe about 10% of all the common antibiotics (1). The antibiotic type, 
regimen and rationale for prescribing can greatly affect the effectiveness of the antibiotic 
and contribute to antibiotic resistance. A limited number of studies have been conducted to 
observe the trend of antibiotic usage in endodontics. Dorn et al. in 1977 surveyed the 
diplomats of American Board of Endodontics (ABE) and reported trends in treatment of 
endodontic emergencies (2, 3). The study was repeated by Gatewood et al. in 1988 (4). 
Whitten et al. 1996 surveyed diplomats of ABE and general dentists to determine treatment 
and antibiotic prescribing practices when treating endodontic cases (5). The most recent 
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study was conducted a decade ago by Yingling et al. in 1999. She surveyed members of 
American Association of Endodontics (AAE) to determine type of most commonly 
prescribed antibiotic, rationale for prescribing, and treatment regimens. The data was 
associated with the experience of the practitioner and the type of practice background (6). 
Yingling’s findings illustrated the lack of standardization in utilizing antibiotics to manage 
and treat endodontic disease. Although most of the dentists were choosing appropriate 
antibiotics to manage endodontic infections, many were prescribing antibiotics 
inappropriately (6). The lack of standardization in prescribing habits first noted in 1977 
was seen to persist to the turn of the century has ultimately contributed to antibiotic 
resistance and ineffectiveness of the drugs in managing true orofacial infections (6). 
In 2007, the American Dental Association (ADA) issued new guidelines, in 
conjunction with the American Heart Association (AHA), for prophylactic antibiotic 
regimen for prevention of infective endocarditis (IE). They recommended antibiotic 
prophylaxis only for patients with underlying cardiac conditions associated with the 
highest risk of adverse outcome from IE (14). A survey published in 2000 by Epstein et al. 
reported that of all licensed dental practitioners in British Columbia, that more than 80 
percent of respondents were following the AHA recommended prophylaxis guidelines 
(15). However, discrepancies in regimen still existed in treating IE, prosthetic joints and 
clinical infections. Based on that survey, it can be assumed that approximately the same 
percentage of practicing dentists in the United States should adapt to the changes in 
prophylaxis protocol.  
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Dentists often prescribed antibiotics in an effort to reduce post operative pain and 
swelling associated with root canal treatment. Studies have shown that the use of penicillin 
in managing postoperative pain and swelling in symptomatic necrotic cases is ineffective 
(12). Studies have also shown the use of prophylactic amoxicillin in prevention of flare-up 
in asymptomatic necrotic teeth is also ineffective (14). With sound evidence base, dentists 
should be able to implement improved protocols and regimens for the use of antibiotics in 
managing endodontic cases. Yingling et al. found that most clinicians were using 
appropriate antibiotics, but many were using them indiscriminately (6). 
The purpose of the study was to determine the changes in prescribing habits of 
active members of American Association of Endodontics (AAE) with regards to antibiotics 
in comparison to the findings reported by Yingling et al. in 1999. 
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MATERIALS AND METHODS 
 
 The survey was constructed based on Yingling et al.’s survey from 1999. 
Certain modifications, such as the omission of questions to determine gender, age, year of 
graduation from dental school or residency, were made since no clinical relevance was 
shown by Yingling el al. In addition, the list of antibiotics were revised and updated to 
ensure that all were current. And, due to the most current update by the AHA/ADA on 
antibiotic prophylaxis, questions were added to determine whether the clinicians were 
aware of and are abiding by the new prophylaxis protocol.  
An invitation to the survey was sent out via email to 2593 members to request 
participation in the survey (See Appendix 1 for invitation email). Those who responded 
were directed to a University web site where the survey was administered online using the 
Inquisite Survey Software (Version 8.0, Inquisite Inc.) (See Appendix 2 for the online 
survey). 
 The results were summarized using frequency counts and percentages. 
Comparisons between the percentages shown in this survey and the previous survey were 
tested using a z-test. An ANOVA model was used to determine the relationships between 
predictive factors and the number of prescriptions written. 
 Pilots surveys were carried out with the part-time endodontic faculty and with the 
residents in the program to determine if the questions were clear and the use of 
terminologies were current.  
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RESULTS  
Invitations were sent via email to 2593 members of AAE. Of these, 355 were 
returned as spam, 2 were not accessible, 6 were not in active practice, 24 were retired, and 
11 were blocked as not deliverable. Of those remaining as potentially eligible to respond to 
the survey (n = 2238), 37.75% responded (n = 845). The results of the survey are presented 
in Tables 1-9. Note that percentages in some instances may not add up to 100% since the 
survey allows for multiple answers within a question, and also that a respondent may 
choose to not answer the questions partially or completely. It was determined that the 
response rate was sufficient for analysis and for comparison with the findings presented by 
Yingling et al. 
Demographics 
 The characteristics of the respondents (n = 845) in this survey are shown in Table 1 
along with the comparable percentages from the survey a decade ago. Demographic data 
solicited for this study varied slightly from the study of 1999. Age, gender, and year of 
graduation were omitted. Additionally, respondents were surveyed as to board certification 
status (American Boards of Endodontics). 
In the study of 1999, most respondents were in private practice. This was also true 
in this study. There was a significant increase in the percentage of respondents in private 
practice (up from 44% to 78%) and a significant decrease in the percentage of respondents 
in part-time academics (down from 52% to 11%). Thirty-nine percent of respondents had 
greater than 20 years of private practice experience, 25% from 11 to 20 years, 18% from 5-
10 years, and 18% with less than 5 years. There was an even distribution of respondents by 
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region. Twenty-five percent of the respondents were board certified through American 
Board of Endodontics (ABE); 74.6% were not. The mean number of patients seen per 
week was 26. This compares to a mean of 35% in the previous survey.  
Table 1: Description of Respondents 
1999
Category of practice n % %
Private (full-time) 649 77.6 44.4
Private (part-time) 44 5.3 2.6
Academics only 49 5.9 1.4
Academics & Private practice 94 11.2 51.6
Years in practice
less than 5 years 148 17.7 8.1
5-10 years 152 18.2 17.0
11-20 years 210 25.1 33.1
more than 20 years 327 39.1 41.7
Region of practice
Northeast 79 9.4 16.8
Midatlantic 153 18.3 15.8
Southeast 108 12.9 15.0
Great Lakes 80 9.5 16.3
Midwest 150 17.9 12.2
Western 235 28.0 22.6
Other 33 3.9 1.3
Board certified in Endodontics
Yes 212 25.4
No 623 74.6
Average number of patients treated in a week
n 831 1586
Mean 26.01 34.88
SD 12.52 16.57
Range 0-130 0-140
2009
 
Antibiotic-Related Topics  
Respondents in this survey wrote an average of 6.8 antibiotic prescriptions per 
week. This is significantly less than the 1999 study (mean=9.25). Twenty-one percent 
reported one prescription per week or less. This was significantly less than the percentage 
reported in 1999 (13%).  
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The average number of prescriptions per week was strongly skewed, therefore, an 
analysis of the log-transformed value was performed. Responses indicating “<1 per week” 
were analyzed as 0.5 and zeroes were analyzed as 0.25. All of the factors listed in Table 1 
were included in an ANOVA model. Average number of patients treated in a week is also 
strongly skewed, therefore, was also analyzed on the log scale.  
The average number of prescriptions per week was not related to practice location 
(p = 0.62), but was related to all of the demographic factors. The average number of 
prescriptions per week was related to the average number of patients seen in a week (p < 
.001) and also related to the category of practice (p < .001). Those in full-time private 
practice write an average of 4.0 prescriptions (95% CI = 2.33-4.20). This is significantly 
more than those in academics alone (mean = 1.8, 95% CI = 1.31-2.59), those in part-time 
academics/private practice (mean = 2.5, 95% CI =2.06-3.08). Those in part-time private 
practice were not significantly different from the other practice categories (mean = 3.1, 
95% CI = 2.33-4.20).  
Years in practice was positively related to the number of prescriptions (p = 0.0006). 
Practitioners with less than 5 years experience prescribed 2.21 prescriptions per week 
(95% CI = 1.80-2.72). The number of prescriptions steadily increased until those with 
more than 20 years of experience prescribed 3.13 per week (95% CI = 2.68-3.67). Board 
certified respondents prescribed fewer prescriptions per week than all other respondents (p 
= 0.039). Those without certification prescribed a mean of 2.54 prescriptions per week 
(95% CI = 2.12-3.04), and those with certification prescribed a mean of 3.01 (95% CI = 
2.62-3.46). This difference was significant.  
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Respondents were queried as to the duration and use of loading dose of antibiotic 
therapy for patients not allergic to penicillin. The average duration of antibiotic therapy 
was 7.04 days, with 79% choosing 7 days. A loading dose was prescribed by 70% with 
96% choosing twice the normal dose. 
Respondents were queried as to the duration and use of loading dose of antibiotic 
therapy for patients allergic to penicillin. The average duration of antibiotic therapy was 
6.89 days, with 77% choosing 7 days. A loading dose was prescribed by 70% with 97% 
choosing twice the normal dose. 
The average duration of antibiotic therapy was 7.58 days in the 1999 study. A 
loading dose of twice the normal dose was reported by 85.14% of those surveyed. 
Respondents were queried as to their first choice and second choice of antibiotic for 
patients with and without allergy to penicillin. Table 2 and 3 represent the antibiotic 
choices, first and second choice respectively, for patients with no medical allergies 
(penicillin allergy) along with the corresponding percentages from the 1999 survey.  
Penicillin VK, 500mg qid, was the first-choice 43.3% of the time for patients with 
no medical allergies. Amoxicillin 500mg tid was the first-choice 37.6% of the time. This 
represents a notable decrease in the use of penicillin VK (61.48% previously to 43.3% 
presently) and a notable increase in the use of amoxicillin (27.51% previously to 37.6% 
presently). Clindamycin was first-choice for 8.1% (150mg qid= 4.6%, 300mg tid/qid= 
3.5%) of respondents. Only 2.8% (150mg qid= 1.91%, 300mg tid/qid= 0.86%) chose 
clindamycin for patients with no penicillin allergies in 1999. 
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Table 2: First Choice Antibiotic Preference for Adult Patients with No Medical 
Allergies (n = 832) 
1999
Choice n % %
Penicillin VK 500mg qid 360 43.3 61.48
Amoxicillin 500mg tid 313 37.6 27.51
Clindamycin (Cleocin®) 150mg qid 38 4.6 1.91
Amoxicillin (Amoxil®) 875mg bid 30 3.6
Clindamycin (Cleocin) 300mg tid/qid 29 3.5 0.86
All others (below) 62 7.5
Ampicillin 500mg qid 14 1.7 2.31
Cephalexin (Keflex) 500mg qid 14 1.7 2.84
Augmentin 500mg tid 13 1.6
Augmentin 875mg bid 10 1.2
Penicillin VK 250mg qid 5 0.6 1.91
Ampicillin 250mg qid 2 0.2 0.59
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 1 0.1
Cephalexin (Keflex®) 250mg qid 1 0.1 0.46
Erythromycin Base 250mg qid 1 0.1 0.00
Tetracycline 500mg qid 1 0.1 0.00
2009
 
  Approximately 38% of respondents chose clindamycin 300mg tid/qid as second-
choice for patients with no medical allergies. Approximately 30% of respondents from the 
previous survey chose clindamycin 150mg qid as the second choice, in comparison to 
26.2% of respondents in 2009. This is a notable increase in the use of clindamycin 300mg 
(15.7% previously to 37.8% presently).  
 Respondents were queried as to their first-choice and second-choice of 
antibiotic for patients with and with allergy to penicillin. Table 4 and 5 represent the 
antibiotic choices, first and second choices respectively, for patients with penicillin allergy 
along with the corresponding percentage from the previous survey.  
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 Clindamycin 300mg tid/qid was the first-choice 53.7% of the time for 
patients with penicillin allergy. This was a notable increase from 21.5% in 1999. 
Clindamycin 150mg qid was the first-choice 36.6% of the time, in comparison to 35.54% 
in 1999. Azithromycin was used 4.1% of the time. This was a notable increase from 2.89% 
in 1999. Use of erythromycin derivatives markedly decreased from 26.6% in 1999 to less 
than 2% in 2009. There was a decrease in use of cephalexin (5.58% to 2.8%).  
Table 3: Second Choice Antibiotic Preference for Adult Patients with No Medical 
Allergies (n = 832) 
1999
Choice n % %
Clindamycin (Cleocin) 300mg tid/qid 282 37.8 15.7
Clindamycin (Cleocin®) 150mg qid 196 26.2 29.6
Amoxicillin 500mg tid 91 12.2 14.5
Penicillin VK 500mg qid 57 7.6 8.9
All others (below) 121 16.2
Augmentin 875mg bid 22 2.9
Augmentin 500mg tid 21 2.8 3.0
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 20 2.7 0.8
Cephalexin (Keflex) 500mg qid 19 2.5 10.7
Metronidazole (Flagyl) 500mg qid 10 1.3 3.1
Amoxicillin (Amoxil®) 875mg bid 9 1.2
Ampicillin 500mg qid 6 0.8 0.8
Cephalexin (Keflex®) 250mg qid 4 0.5 1.8
Metronidazole (Flagyl®) 250mg qid 3 0.4 2.4
Clarithromycin (Biaxin) 500mg tid 2 0.3 0.2
Erythromycin Base 500mg qid 2 0.3 2.0
Cefadroxil (Duricef®) 500mg bid 1 0.1 0.2
Ciprofloxacin (Cipro®) 500mg bid 1 0.1 0.5
Penicillin VK 250mg qid 1 0.1 0.4
2009
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Table 4: First Choice Antibiotic Preference for Adult Patients with Medical Allergies 
(n = 827) 
1999
Choice n % %
Clindamycin (Cleocin) 300mg tid/qid 444 53.7 21.49
Clindamycin (Cleocin®) 150mg qid 303 36.6 35.54
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 34 4.1 2.89
Cephalexin (Keflex) 500mg qid 23 2.8 5.58
All others (below) 23 2.8
Erythromycin Base 500mg qid 7 0.8 9.30
Erythromycin Ethylsuccinate (EES®) 400mg qid 5 0.6 9.71
Erythromycin Base 250mg qid 4 0.5 7.64
Ciprofloxacin (Cipro®) 500mg bid 3 0.4 1.03
Tetracycline 250mg qid 2 0.2 0.21
Amoxicillin 500mg tid 1 0.1 0.41
Cephalexin (Keflex®) 250mg qid 1 0.1 0.41
2009
 
Second-choice for patients with penicillin allergy 38.1% of the time was 
Azithromycin 500mg stat, 250mg qd. This represents a notable increase in the use of 
azithromycin (7.4% previously to 38.1% presently). Approximately 13% (12.5%) chose 
cephalexin 500mg qid as the second-choice. This compares to 9.6% in 1999. Respondents 
chose clindamycin 300mg 8.3% of the time and 150mg 7.8% of the time. This represented 
a decrease in the use of clindamycin from 1999 (300mg: 13.2% previously to 8.3% 
presently; 150mg: 10.9% to 7.8%).  
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Table 5: Second Choice Antibiotic Preference for Adult Patients with Medical 
Allergies (n = 551) 
1999
Choice n % %
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 210 38.1 7.4
Cephalexin (Keflex) 500mg qid 69 12.5 9.6
Clindamycin (Cleocin®) 150mg qid 46 8.3 13.2
Clindamycin (Cleocin) 300mg tid/qid 43 7.8 10.9
All others (below) 183 33.2
Metronidazole (Flagyl) 500mg qid 36 6.5 6.2
Clarithromycin (Biaxin) 500mg tid 26 4.7 7.3
Erythromycin Base 500mg qid 24 4.4 11.2
Erythromycin Base 250mg qid 22 4.0 6.0
Ciprofloxacin (Cipro®) 500mg bid 14 2.5 4.0
Metronidazole (Flagyl®) 250mg qid 11 2.0 6.2
Clarithromycin (Biaxin®) 250mg tid 8 1.5 1.9
Cephalexin (Keflex®) 250mg qid 7 1.3 1.0
Erythromycin Ethylsuccinate (EES®) 400mg qid 7 1.3 12.7
Tetracycline 500mg qid 5 0.9 0.7
Cefadroxil (Duricef®) 500mg bid 4 0.7 0.2
Ciprofloxacin (Cipro) 750mg bid 4 0.7 0.5
Amoxicillin 500mg tid 3 0.5 0.5
Augmentin 500mg tid 3 0.5 0.9
Augmentin 875mg bid 3 0.5 NA
Cefaclor (Ceclor) 500mg qid 2 0.4 0.95
Tetracycline 250mg qid 2 0.4 0.43
Cefaclor (Ceclor®) 250mg qid 1 0.2 0.43
Penicillin VK 500m g qid 1 0.2 0.00
2009
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Table 6: What do you do when no improvement is seen within 2-3 days (1st choice- 
antibiotic to be changed to; 2nd choice- antibiotic to be added)  
Choice n % n %
Clindamycin (Cleocin) 300mg tid/qid 277 36.1 109 21.4
Metronidazole (Flagyl) 500mg qid 148 19.3 135 26.5
Clindamycin (Cleocin®) 150mg qid 142 18.5 38 7.5
Metronidazole (Flagyl®) 250mg qid 61 8.0 40 7.8
Others (listed below) 139 18.1 188 36.9
Augmentin 500mg tid 48 6.3 43 8.4
Augmentin 875mg bid 41 5.3 40 7.8
Amoxicillin 500mg tid 18 2.3 7 1.4
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 9 1.2 38 7.5
Cephalexin (Keflex) 500mg qid 9 1.2 25 4.9
Penicillin VK 500mg qid 5 0.7 8 1.6
Amoxicillin (Amoxil®) 875mg bid 2 0.3
Ciprofloxacin (Cipro®) 500mg bid 2 0.3 7 1.4
Ampicillin 500mg qid 1 0.1 2 0.4
Cefaclor (Ceclor®) 250mg qid 1 0.1
Cefadroxil (Duricef®) 500mg bid 1 0.1 1 0.2
Ciprofloxacin (Cipro) 750mg bid 1 0.1 3 0.6
Clarithromycin (Biaxin) 500mg tid 1 0.1 4 0.8
Cephalexin (Keflex®) 250mg qid 1 0.2
Clarithromycin (Biaxin®) 250mg tid 1 0.2
Erythromycin Base 250mg qid 3 0.6
Erythromycin Base 500mg qid 2 0.4
Tetracycline 250mg qid 1 0.2
Tetracycline 500mg qid 2 0.4
Total expressing a choice 767 510
First choice Second Choice
 
Table 6 represents respondent choices made when queried “What do you do in 
cases where improvement was not seen after 2-3 days with your first-choice of antibiotic?” 
When respondents chose to replace the initial antibiotic, clindamycin was the antibiotic of 
choice 45.6% of the time (300mg 36.1%; 150mg 18.5%). When the respondents chose to 
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add an additional antibiotic to the initial antibiotic, metronidazole was antibiotic of choice 
34.3% of the time (500mg 26.5%; 250mg 7.8%).  
From Table 2, of the respondents (n = 360) who chose penicillin as their first 
choice, 50% chose clindamycin as the replacement antibiotic of choice, and 32% chose to 
add metronidazole to the initial antibiotic. Of respondents (n = 343) whose first choice was 
Amoxicillin, 56% chose clindamycin and 13% chose augmentin as the replacement 
antibiotic of choice, and 19% chose to add metronidazole.  
Antibiotic Usage 
Table 7: Situations in which antibiotics were prescribed  
1999
Situation n % % p-value
Irreversible pulpitis; mod/severe pre-op symptoms 19 2.2 3.5 0.017
Irreversible pulpitis with acute apical periodontitis; 
mod/severe pre-op symptoms
83 9.8 13.3 <.001
Necrotic pulp with chronic apical periodontitis; no 
swelling, no/mild symptoms
136 16.1 18.8 0.029
Necrotic pulp with acute apical periodontitis; no 
swelling, no/mild symptoms
239 28.3 53.9 <.001
Necrotic pulp with chronic apical periodontitis; sinus 
tract present, moderate/severe symptoms
246 29.1 11.9 <.001
Necrotic pulp with acute apical periodontitis; 
swelling present; mod/severe pre-op symptoms
781 92.4 99.2 <.001
Total number of prescribing dentists: 845 1528
2009
  
Table 7 represents the percentage of respondents who prescribed antibiotics for various 
pulpal and periapical diagnoses in 1999 and 2009. The percentages in the two years were 
compared using a z-test. Significant difference was found between the respondents in 1999 
and 2009. 
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A significant decrease in the use of antibiotics in all cases can be noted (p<0.05), 
with the exception of necrotic pulp with chronic apical periodontitis; sinus tract present, 
moderate/severe symptoms where a significant increase was noted in the use of antibiotics 
(11.9% to 29.1% respectively, p<0.001). Significantly less antibiotic were prescribed for: 
irreversible pulpitis with no periapical involvement and mod/severe symptoms (3.5% to 
2.2%, p=0.017); irreversible pulpitis with acute apical periodontitis and mod/severe pre-
op symptons (13.3% to 9.8%, p<0.001); necrotic pulp with chronic apical periodontitis 
with no swelling and no/mild symptoms (18.8% to 16.1%, p=0.029); necrotic pulp with 
acute apical periodontitis with no swelling and no/mild symptoms (53.9% to 28.3%, 
p<0.001); and necrotic pulp with acute apical periodontitis with swelling and mod/severe 
pre-op symptoms (99.2% to 92.4%, p<0.001). 
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Table 8: Situations where antibiotics are routinely prescribed 
1999
Situation n % % p-value
I&D of diffused intraoral swelling with extraoral 
swelling
751 88.9 89.9 0.338
I&D of diffused intraoral swelling, no extraoral 
swelling
554 65.6 69.4 0.020
Avulsions 486 57.5 61.4 0.023
Post treatment flare-ups/pain 425 50.3
I&D of a localized intraoral swelling, no extraoral 
swelling
381 45.1 44.8 0.881
Apicoectomy (root end resection) 281 33.3
Retreatments (Gutta percha/Silver points/etc.) 230 27.2
Re-treatments, silver points 27.0 0.899
Re-treatments, gutta percha 15.4 <.001
Perforations (before/after repair) 73 8.6 9.3 0.468
Interappoint pain 111 13.1
Endodontic surgeries 37.3
Post-op pain after instrumentation and/or 
obturation
12.6
Total number of prescribing dentists: 845 1606
2009
 
Items in italics were in 1999 study but not queried as such in 2009. Silver point and gutta percha retreats 
were grouped, endodontic surgeries were queried as apicoectomy, and post-op pain after instrumentation 
and/or obturation were queried as post treatment flare-ups/pain and interappointment pain. 
   
 
Table 8 lists other endodontic treatment situations and the percentage of 
respondents who prescribed antibiotics routinely for each situation. Approximately 89% of 
respondents prescribed antibiotics for incision and drainage (I&D) of diffused intraoral 
swelling with extraoral swelling. This represents no significant change 1999 (89.9%, 
p=0.338). Antibiotics were prescribed for I&D of diffused intraoral swelling with no 
extraoral swelling 65.6% of the time. This was a significant change from 1999 (69.4%, 
p=0.020). There was a slight increase in antibiotics prescribed for I&D of localized 
intraoral swelling (44.8% to 45.1% respectively).This was not significant (p=0.881). 
Significant decrease in the use of antibiotics for avulsions was noted (61.4% to 57.5% 
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respectively, p=0.023). For perforations, a slight decrease in antibiotics prescribed was 
found (9.3% to 8.6% respectively); but was not significant (p=0.468). Post treatment flare-
ups/pain resulted in 50.3% prescribing antibiotics; 13.1% prescribing for interappointment 
pain; 33.3% for apicoectomy; and 27.2% for retreatment. For the above situations, 
comparisons were not made since terminologies were modified between 1999 and 2009 
(see legend Table 8). 
 Question 16 (see Appendix 2) asked respondents “For which of the following 
special situations are you likely to prescribe antibiotics?”. Of those responding, 52.5% 
indicated that they would prescribe antibiotics if “patient is going on vacation”; 19.1% if 
“patient/referring dentist solicit it”; 14.2% if there is an “upcoming long weekend”; and 
13.4% if “you [the endodontist] are going on vacation”. Other special situations indicated 
by write-in answer included immunocompromised/immunosupressed patients, 
uncontrolled diabetes, and swelling. 
 Question 17 asked the respondents “Have you began using any new prescriptions 
or different antibiotic regimens in the last 12-18 months?”. Ninety-four percent responded 
“No”. Write-in responses for changes included prescribing amoxicillin instead of 
penicillin, increasing amoxicillin dose 875mg bid, prescribing augmentin and/or z-pak 
instead of amoxicillin. 
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Antibiotic Prophylaxis 
Table 9: The situation for which patients were taking antibiotic prophylaxis (1 being 
most common to 4 being least common) 
1 2 3 4 total
patient's medical condition dictates 
the need for prophylactic antibiotic 
regimen
709 (86.8%) 43 (5.3%) 28 (3.4%) 37 (4.5%) 817
referring dentist was prescribing 
using the old AHA/ADA guidelines
50 (7.7%) 131 (20.2%) 165 (25.5%) 301 (46.5%) 647
patient’s personal choice to 
continue with the regimen despite 
being informed of new AHA/ADA 
guideli
16 (2.3%) 125 (18.1%) 335 (48.4%) 216 (31.2%) 692
physician’s choice to keep patient 
on the regimen despite being 
informed of new AHA/ADA 
guidelines
54 (7.1%) 471 (61.6%) 159 (20.8%) 80 (10.5%) 764
Rank
 
Respondents described the situations for which patients were taking prophylactic 
antibiotics, ranking the situations from most common to least common. Most common was  
the patients’ medical condition (86.8%);  followed by physician’s choice to continue with 
the regimen despite being informed of the new AHA/ADA guidelines (61.6%); followed 
by the patient’s choice to continue with the regimen (48.4%); and lastly the referring 
dentist’s lack of awareness for the new AHA/ADA guidelines (46.5%). The results are 
shown in Table 9.   
Approximately 62% (61.8%) of respondents indicated that less than 25% of the 
time patients taking antibiotic prophylaxis actually fall within the new AHA/ADA 
guidelines. Approximately 10% (10.4%) indicated that 25-50% of the patients taking 
antibiotic prophylaxis actually fall within the new AHA/ADA guidelines. Approximately 
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6% (6.4%) and 15 (14.9%) indicated that 51-75% and >75% ,respectively, of the patients 
taking antibiotic prophylaxis actually fall within the new AHA/ADA guidelines. 
Respondents indicated that there were 68.1% who indicated that less than 25% 
were (552/81), 10.4% “between 25 to 50%” (n = 85), 6.4% “51 to 75%” (n = 52), and 
14.9% “more than 75%” (n = 121) In determining how many of the patients fall under the 
new AHA/ADA guidelines. 
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Discussion 
 
 
The results of Yingling’s 1999 on-paper survey (reported in 2000) of the active 
members of AAE suggested that dental practitioners in the field of endodontics may be 
contributing to the indiscriminate overuse of antibiotics. She reported overall prescribing 
habits of endodontists were appropriate for treating orofacial infections (6). However, 
clinicians were prescribing antibiotics when an antibiotic was not indicated (6). Ten years 
have passed since this study. Indiscriminate prescribing habits continue to be reported in 
scientific literature and popular media. Antibiotics continue to be the second most 
commonly prescribed drug. They remain a major contributing factor to the rise in 
antibiotic resistance bacterial strains such as methicillin-resistant Staphylococcus aureus 
(MRSA) (9-12). With increased knowledge often comes change in behavior. This study 
was undertaken to determine if increased awareness over the past ten years resulted in a 
change in antibiotic prescribing behavior.  
With online access more common than in 1999, an online survey, utilizing Inquisite 
Software, rather than paper survey was used for ease of data entry and analysis. Online 
survey instruments have successfully obtained valid information. A large population 
(n=2593) of active members of AAE were sampled (n= 2238). The response rate of 
37.75% (n=845) was deemed acceptable for the online survey and data was deemed 
sufficient for comparison with the results of 1999.  
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The on-paper survey instrument of Yingling et al. served as the model for the online 
survey. Poorly worded questions or ambiguous questions were reworded, but no changes 
were made in content being queried.   
Questions related to demographic data were simplified. Items such as age, gender, 
and year graduated were omitted based on failure to provide relevance in the 1999 survey. 
The question regarding board certification was added as a possible variable in prescribing 
habits. With the recent changes in the ADA/AHA antibiotic prophylaxis guidelines, it was 
fitting to inquire if endodontists were following these guidelines.  
Demographics   
 There was a notable increase in the number of respondents in private practice 
participating in the study (78%) compared with 1999 (44%). This mirrors in the rise of 
AAE members that are in private practice. An increase in the number of clinicians with 10 
years or less in practice responding to the survey (25.1% to 35.9%) can be attributed to the 
ease with which the younger clinicians have embraced the computer technology. These 
practitioners may be more likely to use email in their private practice or home on a daily 
basis.  
In this study, the respondents wrote an average of 6.8 prescriptions per week. This 
is significantly different from the 9.25 prescription written per week in the 1999 survey. 
There was a corresponding decrease in the number of patients being seen per week, with 
34.88 patients seen in 1999 and 26.01 seen in 2009.  The decrease in the number of 
patients seen per week may be explained by economics, treatment philosophy (one vs. two 
visit treatment), and practice model. The decrease in the number of prescriptions written 
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per week may be a reflection of the decrease in the number of patients seen per week, or a 
true decrease in the actual prescribing habits.  
Board certified endodontists prescribed significantly less antibiotics than non-board 
certified endodontists. Mickel et al. reported and discussed the significant differences in 
use of analgesic between board certified and non-board certified endodontists (16). Board 
certified clinicians were less likely than non-board certified clinicians to use non-narcotic 
analgesics to manage pain and more likely to avoid the use of medicine to manage post-
operative pain (16). These two studies suggest that board certified endodontists’ 
prescribing habits differ from non-board certified endodontists. The findings also support 
the premise that increased knowledge and increased awareness result in change in 
behavior.  
Antibiotic-Related Topics 
 Antibiotics should be used as an adjunct to appropriate clinical treatment, and 
should be prescribed only in cases of persistent infections with indication of systemic 
involvement, such as fever, swelling, lymphadenopathy, or malaise. Immunocompromised 
patients and those with underlying systemic diseases may require antibiotics (17). 
Odontogenic infections are polymicrobial, typically having rapid onset and short duration. 
Pallash discussed that proper dose and duration of an antibiotic is enough when there is 
sufficient evidence that the patients' host defenses can manage the infection. Duration of 5-
7 days and the use of a loading dose are appropriate for treating oral infections (18). 
Seventy-seven to 79% of clinicians in this study chose a regimen of 7 days. A loading dose 
was used by 70%, with 96% to 97% choosing twice the normal dose as the loading dose.  
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Previously, clinicians reported using a loading dose 85.14% of the time, an average 
duration of 7.58 days, and a loading dose of twice the normal dose. There was no 
difference noted between the two surveys in the number of days an antibiotic was 
prescribed. Loading doses continued to be prescribed to achieve rapid therapeutic blood 
levels of the antibiotics due to the acute nature of the orofacial infections (6, 18).  
Antibiotic Preferences 
The online survey contained a similar list of antibiotics found on the previous 
survey. Appropriate modifications and additions were made to assure that the antibiotic list 
included the most currently prescribed antibiotics for the management of orofacial 
infections. 
 Yingling et al. reported penicillin VK 500 mg qid was the first-choice of antibiotic 
for patients who were not allergic to penicillin, being use by 61.48% of respondents (6). 
This survey showed a reduction in the use of penicillin VK (500mg qid), as the first choice 
of antibiotic, with 43.3% prescribing. There was a corresponding increase in the use of 
amoxicillin (500mg tid) from 27.51% to 37.6%. The increase in the use of amoxicillin in 
lieu of penicillin may be due to the ease of use and patience compliance since penicillin 
has to be taken 4 times a day before meals while amoxicillin can be taken 3 times per day 
with or without food. The cost of amoxicillin is slightly higher than penicillin, however it 
is a suitable alternative since it is readily absorbed, and is only taken 3 times per day due to 
the longer half-life and more sustained serum levels. Amoxicillin, a broader spectrum 
antibiotic than penicillin, used in a healthy individual may contribute to antibiotic 
resistance (6).  
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Of concern is the 8.1% (4.6% 150 mg qid + 3.5% 300mg tid/qid) of respondents in 
this survey who chose clindamycin as first-choice for patients not allergic to penicillin. 
This compares with 1.9% of respondents choosing clindamycin as first-choice in 1999. 
Sixty-four percent respondents chose clindamycin (37.8% 300mg tid/qid + 26.2% 150mg 
qid) as the second-choice for patients not allergic to penicillin. This compares with 45.3% 
(15.7% 300mg tid/qid + 29.6% 150mg qid) in 1999. Clindamycin is a broader spectrum 
antibiotic than penicillin, but has a narrower specificity for oral pathogens. It is associated 
with the risk for pseudomembraneous colitis, higher in cost, and leaves the clinician 
without a second-choice drug when penicillin or amoxicillin fail to control the odontogenic 
infection. It is an inappropriate initial antibiotic choice for patients not allergic to 
penicillin.  
Penicillin is still the antibiotic of choice with less risk, lower cost, and less 
contribution to antibiotic resistance (6). Baumgartner and Xia, in their article regarding 
antibiotic susceptibility testing of bacteria associated with endodontic abscesses, discussed 
the need for careful consideration of choice of antibiotics. They reported that penicillin VK 
is still the antibiotic of choice in polymicrobial infections with relatively narrow spectrum 
such as odontogenic infections (20).  
Clindamycin is an appropriate alternative for patients with penicillin allergy. 
Approximately 90% (53.7% 300mg tid/qid + 36.6% 150mg qid) of respondents chose 
clindamycin as the first-choice of antibiotic for penicillin-allergic patients. This was 
compared with 56.03% (21.49% 300mg tid/qid + 35.54% 150mg qid) in 1999. High cost 
and the risk for pseudomembraneous colitis exist; however, the risk is less compared to 
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ampicillin and cephalosporins. Clindamycin has good absorption for gastro-intestinal tract, 
reach a peak concentration within 60 minutes, and has good bone penetration (6). 
Baumgartner and Xia reported susceptibility for clindamycin to bacteria found in 
odontogenic infections to be 96% (20).  
A significant decrease in the use of erythromycin (base or salt) as first-choice and 
second-choice antibiotic in penicillin-allergic patients was noted. When dosages (base and 
salt) were combined, 1.9% of respondents chose erythromycin as first-choice as compared 
to 26.65% in 1999. As a second-choice, 10.4% of respondents chose erythromycin as 
compared to 29.9% in 1999 (combined dosages). Erythromycin, a microlide, has similar 
spectrum of activity as penicillin for Gram-positive microorganisms, but is not considered 
a good choice for odontogenic infections since it is not as effective against anaerobe, and 
has a high incidence of gastrointestinal distress (6). These findings support the premise that 
increased knowledge and increased awareness result in change of behavior. 
 
A slight increase in the use of azithromycin (Z-Pak) as first-choice for penicillin-
allergic patients was noted along with a steep increase in the use of azithromycin (Z-Pak) 
as second-choice (7.4% to 38.1%). Azithromycin (Z-Pak), a semi synthetic derivative of 
erythromycin, has a broader spectrum of activity, improved tissue penetration, decreased 
dosing regimen due to increased half-life, and lower incidence of gastrointestinal distress 
(19). The steep increase is most likely due to the user friendly once or twice daily dosing 
schedule, and its current “in vogue” status.  
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 For the scenarios of improvement not seen with the first choice of antibiotics, 
penicillin or amoxicillin, most clinicians chose to switch to clindamycin, while some added 
metronidazole (Flagyl). Others chose to switch to augmentin (amoxicillin with 
calvulanate). Metronidazole is very effective against obligate anaerobes but not against 
facultative anaerobes. This addition of metronidazole can be considered appropriate based 
on Baumgartner's susceptibility report. Metronidazole used in combination with penicillin 
and amoxicillin resulted in a susceptibility of 93% and 99% respectively (20). AAE's 
College of Excellence Report in '99 supported the addition of metronidazole to the regimen 
of penicillin. (21). 
Antibiotic Usage 
Pulpal and periapical diagnosis scenarios (Table 7), along with endodontic 
treatment scenarios most likely to elicit antibiotic usage (Table 8) were surveyed. These 
scenarios pertained only to basic tooth diagnosis and treatment, and did not involve in-
depth symptoms/findings and patient’s medical/systemic health status. Given more 
information or specific patient scenarios, respondents may have made different choices.  
 Yingling et al. reported that endodontists were using antibiotics in inappropriate 
situations such as irreversible pulpitis cases (16.76%) and necrotic cases with no swelling 
and mild symptoms (53.59%) (6). This inappropriate use continues, yet a positive change 
was noted with a significant decrease in use of antibiotics in all diagnosis situations (Table 
7). Antibiotic use in irreversible pulpitis cases declined significantly from 16.67% to 12% 
at present. For necrotic cases with chronic apical periodontitis, no swelling and mild 
symptoms, a significant improvement was seen with a decline of 2.7% (18.8% in 1999 to 
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16.1% at present). This 16.1% was a steep decline from the 35.7% reported by Whitten et 
al. (5). Approximately 28% (28.3%) of respondents chose to prescribe antibiotics for the 
diagnosis of necrotic pulp with acute apical periodontitis, no swelling and no/mild 
symptoms. This was a significant decrease from 53.9% in 1999 (p<0.001). This is a 
positive trend when compared to reports by Dorn et al. (30.0%), Gatewood et al. (33.1%), 
and Whitten et al. (67.3%) (2-5). For necrotic pulp with acute apical periodontitis with 
swelling and moderate to severe symptoms, 92.4% prescribed antibiotics. This was a 
significant decrease from 99.2% reported in 1999 (p<0.001). The exception to the above 
positive changes was the diagnosis of necrotic pulp with chronic apical periodontitis with 
sinus tract present and with moderate to severe symptoms. A significant increase from 
11.9% previously to 29.1% at present (p<0.001) was noted. This exception can be a result 
of the change in diagnosis situation of symptoms from no or mild symptoms in 1999 to 
mod/severe in the present survey.  
 Although a significant decrease in the use of antibiotics above is a promising trend, 
the use of antibiotics are not indicated in the given scenarios, with the exception of 
“necrotic pulp with acute apical periodontitis; swelling present; mod/severe pre-op 
symptoms”. Nonsurgical root canal therapy without antibiotics was adequate to treat 
irreversible pulpitis with acute and chronic apical periodontitis, draining sinus tract, and 
mild swelling. Removing the source of the infection usually allows for healing without the 
need for antibiotics. Systemic antibiotics will not reach a therapeutic concentration level to 
be effective locally due to poor circulation of the pulp and periradicular tissue. 
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Clinicians may incorrectly choose to prescribe antibiotics to decrease pain 
associated with pulpitis or periapical periodontitis. Keenan et al., in their Cochrane 
Systemic Review, reported Nagle et al.'s paper, which showed that there was no significant 
difference in pain relief for patients with untreated irreversible pulpitis who received 
antibiotics versus those who did not (22, 23). Several studies have been published to show 
that antibiotics are neither effective in preventing pain nor swelling when used 
preoperatively and postoperatively in routine endodontic cases. Henry et al., in a study of 
symptomatic necrotic teeth with periapial lesions, concluded that penicillin administered 
post operatively did not significantly reduce pain, percussion pain, or the number of 
analgesic medications taken (24). This finding was confirmed by Fouad et al. in 1996 (25). 
Walton and Chiappinelli (1993) also reported that administration of penicillin as 
prophylaxis has no significant effect on post-treatment signs and symptoms in cases of 
asymptomatic periapical pathosis (26). The most effective treatment to decrease pain 
remains the use of analgesics and anti-inflammatory medications. 
 In other treatment scenarios (Table 8), such as incision and drainage, avulsions, 
apicoectomies, and retreatments, there was a generalized decreased in number of antibiotic 
prescriptions. There was a significance decrease noted for I&D of diffuse intraoral 
swelling with no extraoral swelling (69.4% in 1999 to 65.6% presently), and avulsions 
(61.4% in 1999 to 57.5% presently). No comparison can be made between the two studies 
regarding endodontic surgeries, retreatments, and interappoint flare-up/pain due to the 
changes in the terminology between the surveys. 
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 It was shocking to note that 50% of the respondents were using antibiotics to 
manage post treatment flare-ups and pain, while 13% were using antibiotics for inter-
appointment pain. As noted above, there was no evidence to support the use of antibiotics 
in managing inter-appointment pain and post-operative pain and flare up. Pickenpaugh et 
al. reported that prophylactic amoxicillin did not significantly influence the endodontic 
flare-up outcomes (27). 
 Unsettling is the trend that about 19% were prescribing antibiotics to appease their 
patients and referring dentists. This is a common finding in private practice setting where 
clinicians are forced to provide antibiotic prescriptions to ease the patients' apprehension or 
accommodate the desire of a referring dentist. Those respondents admitting to this practice 
stated that they inform the patient to hold the prescription and fill only after they had called 
the office or presented with specific symptoms (write-in responses).  
Antibiotic Prophylaxis  
The antibiotic prophylaxis regimen for preventing infective endocarditis (IE) has 
been recently updated. In June of 2007, the American Heart Association (AHA) along with 
ADA, issued new recommended guidelines which stated that IE prophylaxis for dental 
procedures should be recommended only for patients with underlying cardiac conditions 
associated with the highest risk of adverse outcome from IE, and is not recommended 
based solely on an increased lifetime risk of acquisition of IE (14). The rationale behind 
the revision of the recommendations was that the risk of antibiotic-associated adverse 
events exceeds the benefit since prophylaxis may prevent an exceedingly small number of 
cases of IE (14). Based on the survey, majority of the clinicians stated that, of the patients 
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who need antibiotic prophylaxis, less then 25% actually fall under the new AHA/ADA 
recommended guidelines.  
Conclusion 
 This survey illustrated that the majority of private practice endodontists were 
choosing appropriate antibiotics and prescribing regimens for the treatment of endodontic 
related infections. An improved trend was noted by the decreased in use of antibiotics in 
managing various endodontic scenarios given. Tendencies to indiscriminately prescribe 
antibiotics when not indicated were still seen. Yingling in 1999 stated that “the most 
important decision for the dental practitioner to make is not which antibiotic to use but 
whether to use one at all” (6).  
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Appendix 1 
Letter of Invitation for the Survey 
 
Dear [LAST NAME], 
 
In 2002 we published the results of a survey designed to determine the antibiotics 
prescribing habits of active members of the American Association of Endodontics. 
Prescribing habits have changed since then….or have they? 
 
Please take a few minutes and complete this 2009 survey to assist us in determining the 
current prescribing habits of endodontists. It will aid the endodontic specialty by providing 
awareness and improve the trends in the use of antibiotics. 
 
Your participation is voluntary and you may stop the survey at any point. Rest assured that 
your answers are to be used only for research purposes and your anonymity will be 
maintained.  
  
Thank you very much for your cooperation. 
 
Click the following link to start... 
[SURVEY LINK] 
 
Sincerely, 
 
Karan J. Replogle, DDS, MS 
Interim Chairman and Program Director 
Department of Endodontics 
VCU School of Dentistry 
520 North 12th Street 
P.O. Box 980566 
Richmond, VA 23298-0566. 
 
For your reference the previous paper was Yingling, Byrne & Hartwell (2002) “Antibiotic 
use by members of the American Association of Endodontics in the year 2000: report of a 
national survey” Journal of Endodontics, 28(5), 396-404. 
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Appendix 2 
 
Online Survey 
 
 
 
 
Type of Practice (choose one): 
 
 
 
 
Private (full-time) 
 
 
 
Private (part-time) 
 
 
 
Academics 
 
 
 
Academics & Private practice 
 
 
 
 
Years in Practice (choose one): 
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less than 5 years 
 
 
 
5-10 years 
 
 
 
11-20 years 
 
 
 
more than 20 years 
 
 
 
 
Practice location (choose one): 
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Northeast (MA, RI, CT, VT, NH, ME, NY, NJ) 
 
 
 
Mid Atlantic (PA, MD, DE, WV, VA, NC, SC, DC) 
 
 
 
Southeast (KY, TN, AR, LA, MS, AL, GA, AL) 
 
 
 
Great Lakes (MN, WI, IL, IN, MI, OH) 
 
 
 
Mid West (NM, CO, WY, MT, ND, SD, NE, KS, OK, TX, IA, MO) 
 
 
 
Western (WA, OR, CA, ID, NV, UT, AZ, AK, HI) 
 
 
 
Other 
 
 
 
 
Are you Board Certified in Endodontics? 
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Yes 
 
 
 
No 
 
 
 
 
Average number of patients treated in a week: 
 
 
 
Average number of prescription for antibiotics in a week: 
 
 
 
Antibiotic preference for adult patients with no medical allergies: 
(place 1 most often prescribed; place 2 for 2nd most often) 
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 Amoxicillin 500mg  tid 
 
 
 
 Amoxicillin (Amoxil®) 875mg bid 
 
 
 
 Ampicillin 250mg qid 
 
 
 
 Ampicillin 500mg qid 
 
 
 
 Augmentin 500mg tid 
 
 
 
 Augmentin 875mg bid 
 
 
 
 Azithromycin (Z-PAK®) 500mg stat, 250mg qid 
 
 
 
 Cefaclor (Ceclor®) 250mg qid 
 
 
 
 Cefaclor (Ceclor) 500mg qid 
 
 
 
 Cefadroxil (Duricef®) 500mg bid 
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 Cephalexin (Keflex®) 250mg qid 
 
 
 
 Cephalexin (Keflex) 500mg qid 
 
 
 
 Ciprofloxacin (Cipro®) 500mg bid 
 
 
 
 Ciprofloxacin (Cipro) 750mg bid 
 
 
 
 Clarithromycin (Biaxin®) 250mg tid 
 
 
 
 Clarithromycin (Biaxin) 500mg tid 
 
 
 
 Clindamycin (Cleocin®) 150mg qid 
 
 
 
 Clindamycin (Cleocin) 300mg tid/qid 
 
 
 
 Erythromycin Ethylsuccinate (EES®) 400mg qid 
 
 
 
 Erythromycin Base 250mg qid 
 
 
 
 Erythromycin Base 500mg qid 
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 Metronidazole (Flagyl®) 250mg qid 
 
 
 
 Metronidazole (Flagyl) 500mg qid 
 
 
 
 Penicillin VK 250mg qid 
 
 
 
 Penicillin VK 500mg qid 
 
 
 
 Tetracycline 250mg qid 
 
 
 
 Tetracycline 500mg qid 
 
 
 
 Other 
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Number of days prescribed: 
 
 
 
 
Less than 5 days 
 
 
 
5 days 
 
 
 
7 days 
 
 
 
10 days 
 
 
 
14 days 
 
 
 
More than 14 days 
 
 
 
 
Do you use a loading dose when prescribing antibiotic selected above? 
 
 
  42
 
 
Yes 
 
 
 
No 
 
 
 
 
If yes, what is the dosage?: 
 
 
 
 
2x the normal dose 
 
 
 
3x the normal dose 
 
 
 
Other 
 
 
 
 
 
 
 
Antibiotic preference for adult patients with penicillin allergy (Place 1 most often 
prescribed; place 2 for 2nd most often): 
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Amoxicillin 500mg tid 
 
 
 
Amoxicillin (Amoxil®) 875mg bid 
 
 
 
Ampicillin 250mg qid 
 
 
 
Ampicillin 500mg qid 
 
 
 
Augmentin 500mg  tid 
 
 
 
Augmentin 875mg bid 
 
 
 
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 
 
 
 
Cefaclor (Ceclor®) 250mg qid 
 
 
 
Cefaclor (Ceclor) 500mg qid 
 
 
 
Cefadroxil (Duricef®) 500mg bid 
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Cephalexin (Keflex®) 250mg qid 
 
 
 
Cephalexin (Keflex) 500mg qid 
 
 
 
Ciprofloxacin (Cipro®) 500mg bid 
 
 
 
Ciprofloxacin (Cipro) 750mg bid 
 
 
 
Clarithromycin (Biaxin®) 250mg tid 
 
 
 
Clarithromycin (Biaxin) 500mg tid 
 
 
 
Clindamycin (Cleocin®) 150mg qid 
 
 
 
Clindamycin (Cleocin) 300mg tid/qid 
 
 
 
Erythromycin Ethylsuccinate (EES®) 400mg qid 
 
 
 
Erythromycin Base 250mg qid 
 
 
 
Erythromycin Base 500mg qid 
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Metronidazole (Flagyl®) 250mg qid 
 
 
 
Metronidazole (Flagyl) 500mg qid 
 
 
 
Penicillin VK 250mg qid 
 
 
 
Penicillin VK 500mg qid 
 
 
 
Tetracycline 250mg qid 
 
 
 
Tetracycline 500mg qid 
 
 
 
Other 
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Number of days prescribed: 
 
 
 
 
Less than 5 days 
 
 
 
5 days 
 
 
 
7 days 
 
 
 
10 days 
 
 
 
14 days 
 
 
 
More than 14 days 
 
 
 
 
Do you use a loading dose when prescribing antibiotic selected above? 
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Yes 
 
 
 
No 
 
 
 
 
If yes, what is the dosage?: 
 
 
 
 
2x the normal dose 
 
 
 
3x the normal dose 
 
 
 
Other 
 
 
 
 
 
 
 
What do you do in cases where improvement is not seen after 2-3 days with your first 
choice of antibiotic? (Place 1 most often prescribed; place 2 for 2nd most often): 
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Amoxicillin 500mg tid 
 
 
 
Amoxicillin (Amoxil®) 875mg bid 
 
 
 
Ampicillin 250mg qid 
 
 
 
Ampicillin 500mg qid 
 
 
 
Augmentin 500mg  tid 
 
 
 
Augmentin 875mg bid 
 
 
 
Azithromycin (Z-PAK®) 500mg stat, 250mg qid 
 
 
 
Cefaclor (Ceclor®) 250mg qid 
 
 
 
Cefaclor (Ceclor) 500mg qid 
 
 
 
Cefadroxil (Duricef®) 500mg bid 
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Cephalexin (Keflex®) 250mg qid 
 
 
 
Cephalexin (Keflex) 500mg qid 
 
 
 
Ciprofloxacin (Cipro®) 500mg bid 
 
 
 
Ciprofloxacin (Cipro) 750mg bid 
 
 
 
Clarithromycin (Biaxin®) 250mg tid 
 
 
 
Clarithromycin (Biaxin) 500mg tid 
 
 
 
Clindamycin (Cleocin®) 150mg qid 
 
 
 
Clindamycin (Cleocin) 300mg tid/qid 
 
 
 
Erythromycin Ethylsuccinate (EES®) 400mg qid 
 
 
 
Erythromycin Base 250mg qid 
 
 
 
Erythromycin Base 500mg qid 
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Metronidazole (Flagyl®) 250mg qid 
 
 
 
Metronidazole (Flagyl) 500mg qid 
 
 
 
Penicillin VK 250mg qid 
 
 
 
Penicillin VK 500mg qid 
 
 
 
Tetracycline 250mg qid 
 
 
 
Tetracycline 500mg qid 
 
 
 
Other 
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In which of the situations would you prescribe antibiotics? (Check all that apply; leave 
blank if no antibiotics are to be prescribed): 
 
 
 
 
 Irreversible pulpitis; mod/severe pre-op symptoms 
 
 
 
 Irreversible pulpitis with acute apical periodontitis; mod/severe pre-op symptoms 
 
 
 
 Necrotic pulp with chronic apical periodontitis; no swelling, no/mild symptoms 
 
 
 
 Necrotic pulp with acute apical periodontitis; no swelling, no/mild symptoms 
 
 
 
 Necrotic pulp with chronic apical periodontitis; sinus tract present, moderate/severe 
symptoms 
 
 
 
 Necrotic pulp with acute apical periodontitis; swelling present; mod/severe pre-op 
symptoms 
 
 
 
 
In which of the following situations do you routinely prescribe antibiotics? (Check all that 
apply): 
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 Avulsions 
 
 
 
 Post treatment flare-ups/pain 
 
 
 
 Interappoint pain 
 
 
 
 Retreatments (Gutta percha/Silver points/etc.) 
 
 
 
 Perforations (before/after repair) 
 
 
 
 Apicoectomy (root end resection) 
 
 
 
 I&D of localized intraoral swelling, no extraoral swelling 
 
 
 
 I&D of diffused intraoral swelling, no extraoral swelling 
 
 
 
 I&D of diffused intraoral swelling with extraoral swelling 
 
 
 
 
For which of the following special situations are you likely to prescribe antibiotics? 
(Check all that apply); leave blank if no antibiotics are to be prescribed: 
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You are going on vacation 
 
 
 
Patient is going on vacation 
 
 
 
Upcoming long weekend 
 
 
 
Patient/Referring dentist solicit it 
 
 
 
Other 
 
 
 
 
 
 
 
Have you begun using any new prescriptions or different regimens in the last 12- 18 
months? 
 
 
 
 
Yes 
 
 
 
No 
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If yes, what antibiotic(s) 
 
 
 
If yes, why? 
 
 
 
Which of the following describe the situation for which your patients are taking 
prophylactic antibiotic? (Please rank using numbers 1-4, 1=most common to 4=least 
common) 
 
 
 
 
 
 patient's medical condition dictates the need for prophylactic antibiotic regimen 
 
 
 
 referring dentist was prescribing using the old AHA/ADA guidelines 
 
 
 
 patient’s personal choice to continue with the regimen despite being informed of new 
AHA/ADA guidelines 
 
 
 
 physician’s choice to keep patient on the regimen despite being informed of new 
AHA/ADA guidelines 
 
 
 
 
How many of your patients who need prophylactic antibiotics actually fall under the new 
AHA/ADA antibiotic prophylactic guidelines? 
(see http://ada.org/public/topics/antibiotics.asp) 
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Less than 25% 
 
 
 
25 to 50% 
 
 
 
51 to 75% 
 
 
 
More than 75% 
 
 
 
 
Comments: 
 
 
 
Thank you for your participation! 
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VITA 
 
Pye P. E Kyu, DDS, was born in Rangoon (Yangon), Burma (Myanmar) in 
Southeast Asia. He lived in Kingston, Jamaica, from the age of 10 to 16 years old, where 
he completed his high school education before moving to Chesapeake, Va. He attended 
Old Dominion University and graduated with a BS in Biology in 2002 followed by 
receiving a DDS from VCU School of Dentistry in 2006. He then went onto attaining a 
certificate in Advance Education in General Dentistry from Vcu School of Dentistry in 
2007 before joining the Endodontic Residency at Vcu School of Dentistry. He is apart of 
Omicron Kappa Upsilon (OKU) and Delta Sigma Delta (DSD) dental societies, and he is 
an active  participant of Mission of Mercy Projects and other dental projects throughout 
rural Virginia and local communities.  
He currently is pursing a solo endodontic practice in Chesapeake, Va.  
   
 
 
